Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Cypress Pointe Urology Announces Dr. Ralph Vincent Kidd III Designation as UroLift® Center of Excellence

Cypress Pointe Urology
Posted on: 16 Aug 18
Cypress Pointe Urology Announces Dr. Ralph Vincent Kidd III Designation as UroLift® Center of Excellence Designation Recognizes Dr. Kidd's Commitment to Exemplary Care, Deep UroLift Experience

PR Newswire

HAMMOND, La., August 16, 2018

HAMMOND, La., August 16, 2018 /PRNewswire-PRWeb/ -- Cypress Pointe Urology today announced that Ralph Vincent Kidd III, MD has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Kidd has achieved a high level of training and experience with the UroLift System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia or BPH.

"The UroLift System is a breakthrough minimally invasive treatment that typically takes less than an hour and can offer multiple benefits for men with enlarged prostate – no cutting, heating, or removal of tissue, minimal downtime, no compromise of sexual function, and no need for continued medications," said Dr. Kidd. "We are proud to be a national leader in treating patients with this durable and effective treatment."

Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life.

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.

About the UroLift System
NeoTract's FDA-cleared UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About Cypress Pointe Urology
Dr. Ralph Vincent Kidd III of Cypress Pointe Urology has been practicing Urology in Hammond for over 30 years. Dr. Kidd has served thousands of patients in Southeast Louisiana and Mississippi and still has a patient base of over twenty thousand patients across the area, which makes CPU one of the largest single provider urology clinics in the state. Dr. Kidd specializes in adult and pediatric urology for the treatment of various urologic conditions and diseases that include kidney stones, erectile dysfunction, urinary retention, and male and female incontinence.

Media Contact:
Brandon Recotta
(985)510-6227
Brecotta(at)cpsh.org

 

SOURCE Cypress Pointe Urology

PR Newswire
www.prnewswire.com

Last updated on: 16/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.